RNA sequencing identified how venetoclax influences the phenotypic and qualitative changes in CAR T cells

Google+ Pinterest LinkedIn Tumblr +




New work from Roswell Park adds evidence that FDA-approved leukemia drug improves T cell quality and function Standard therapies prove ineffective for a third of patients with DLBCL  Roswell Park team studying whether Bcl-2-inhibiting drug may enhance CAR T  Underlying mechanism hinges on calcium signaling, scientists reveal  About a third of patients with diffuse …

Share.